The therapeutic potential of CFTR modulators for COPD and other airway diseases.

about

Cigarette Smoke-Induced Acquired Dysfunction of Cystic Fibrosis Transmembrane Conductance Regulator in the Pathogenesis of Chronic Obstructive Pulmonary Disease.Ion Channel Modulators in Cystic Fibrosis

P2860

Q54962564-FE5C5BEE-3EBA-4AF3-830E-5F628B66E8D7 Q56966061-A5E456FE-7070-4B59-8A60-612B58D014AA

P2860

The therapeutic potential of CFTR modulators for COPD and other airway diseases.

Item

http://www.wikidata.org/entity/Q50046887

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

The therapeutic potential of CFTR modulators for COPD and other airway diseases.

@en

The therapeutic potential of CFTR modulators for COPD and other airway diseases.

@nl

type

Item

label

The therapeutic potential of CFTR modulators for COPD and other airway diseases.

@en

The therapeutic potential of CFTR modulators for COPD and other airway diseases.

@nl

prefLabel

The therapeutic potential of CFTR modulators for COPD and other airway diseases.

@en

The therapeutic potential of CFTR modulators for COPD and other airway diseases.

@nl

P1476

The therapeutic potential of CFTR modulators for COPD and other airway diseases.

@en

P2093

George M Solomon

http://www.w3.org/2001/XMLSchema#string

James F Collawn

http://www.w3.org/2001/XMLSchema#string

Lianwu Fu

http://www.w3.org/2001/XMLSchema#string

Steven M Rowe

http://www.w3.org/2001/XMLSchema#string

P2860

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease

Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease

Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770

'CFTR-opathies': disease phenotypes associated with cystic fibrosis transmembrane regulator gene mutations

Chronic bronchitis and chronic obstructive pulmonary disease

Will chronic e-cigarette use cause lung disease?

A pharmacologic approach to acquired cystic fibrosis transmembrane conductance regulator dysfunction in smoking related lung disease

Cadmium regulates the expression of the CFTR chloride channel in human airway epithelial cells

Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease

Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994.

P304

132-139

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.COPH.2017.09.013

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-11-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29132121

http://www.w3.org/2001/XMLSchema#string

P921

chronic obstructive pulmonary disease

P932

5723211

http://www.w3.org/2001/XMLSchema#string

The therapeutic potential of CFTR modulators for COPD and other airway diseases.

about

P2860

P2860

The therapeutic potential of CFTR modulators for COPD and other airway diseases.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P921

P932